Naoko Okiyama

Deep‐learning‐based, computer‐aided classifier developed with a small dataset of clinical images surpasses board‐certified dermatologists in skin tumour diagnosis

Yasuhiro Fujisawa, Yasuhiro Otomo, Yousuke Ogata et al. · British Journal of Dermatology · 2018 · 314 citations

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

Satoshi Ebata, Ayumi Yoshizaki, Koji Oba et al. · The Lancet Rheumatology · 2021 · 238 citations

Systemic Scleroderma, Systemic Treatment, Immunology +6

Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies

Yoshiyuki Nakamura, Ryota Tanaka, Hiroshi Maruyama et al. · Japanese Journal of Clinical Oncology · 2018 · 112 citations

Therapeutic effects of interleukin‐6 blockade in a murine model of polymyositis that does not require interleukin‐17A

Naoko Okiyama, Takahiko Sugihara, Yoichiro Iwakura et al. · Arthritis & Rheumatism · 2009 · 95 citations · Full text

Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis

Manabu Fujimoto, Akihiro Murakami, Shunsuke Kurei et al. · Journal of Dermatological Science · 2016 · 84 citations

Enzyme-linked Immunosorbent Assays, Autoimmune Disease, Immunodeficiencies +12